INDOFARM
Indo Farm Equipment Ltd.
Each stock's 10,000-path forecast, rendered as light.
Indo Farm Equipment Ltd. (INDOFARM) Stock Analysis & Case Study
Is INDOFARM a good buy? The data-driven verdict.
Indo Farm Equipment Ltd. (INDOFARM) trades at ₹159,on the numbers it tread carefully, a Downstox Snapshot Score of 34/100.
On the numbers, Indo Farm Equipment Ltd. (INDOFARM) tread carefully, a Downstox Snapshot Score of 34/100, weighing premium at 30.6× earnings, ROE of 4.5%, a 47% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027-2031.
Last updated . Data snapshot for research, not investment advice.
INDOFARM fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
How INDOFARM ranks against the 2,373 companies in our screener
- INDOFARM's market cap of 764 Cr ranks in the 34th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- INDOFARM's book value of ₹116 ranks in the 56th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- INDOFARM's promoter holding of 70.6% ranks in the 76th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- INDOFARM's 3-year profit (PAT) growth of 15.0% ranks in the 49th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- INDOFARM's 3-year revenue growth of 7.0% ranks in the 41st percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- INDOFARM's debt-to-equity ratio of 0.27x is lower than 55% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
Is INDOFARM overvalued? INDOFARM P/E vs peers
INDOFARM trades at 30.6× earnings. We don't have a verified sector peer group for this stock yet, so no sector peer median or peer comparison table is shown here. Showing one anyway would compare it against an arbitrary set of large-cap names, not real sector peers.
INDOFARM share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 1.6y of INDOFARM history (-35%/yr drift, 54%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| INDOFARM 2027 | ₹76 | ₹153 | ₹308 | -4% |
| INDOFARM 2028 | ₹54 | ₹147 | ₹394 | -8% |
| INDOFARM 2029 | ₹42 | ₹141 | ₹469 | -12% |
| INDOFARM 2030 | ₹34 | ₹135 | ₹537 | -15% |
| INDOFARM 2031 | ₹28 | ₹130 | ₹610 | -18% |
Median (P50) is the central estimate; the P10-P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability INDOFARM goes up, or doubles?
The bull case for INDOFARM
- Low price-to-book of 1.37×, the market is paying little over the company's net assets.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹469.
The bear case & risks
- INDOFARM's P/E of 30.6x is lower than 45% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- INDOFARM's return on equity of 4.5% ranks in the 28th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- High historical volatility (54%/yr) means a wide, bumpy range of outcomes, size positions accordingly.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹42.
INDOFARM volatility & expected range, how bumpy is the ride?
Over the last 1.6 years INDOFARM compounded at -35%/year with annualized volatility of 54%. That volatility implies a 1-year 80% range of ₹76-₹308, the honest backbone behind any single price target.
INDOFARM price forecast, the full 60-month probability fan
INDOFARM price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds INDOFARM hits common targets within the simulated horizon?
Full multi-horizon detail on the INDOFARM price target & forecast page.
INDOFARM Piotroski F-Score: 5/8, how financially strong is it?
The Piotroski F-Score grades financial strength on profitability, leverage and efficiency checks. Downstox scores the eight checks it can verify from published filings, so 8 is full marks. INDOFARM scores 5/8, mixed financial health.
INDOFARM MTF margin & leverage across 7 brokers
Margin Trading Facility lets you buy INDOFARM with part of the capital. Lower margin % = higher leverage. Rates compared across 7 brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| ZerodhaCHEAPEST | 37.92% | 2.6× |
| Groww | 60.00% | 1.7× |
| Dhan | 50.00% | 2.0× |
| Kotak Neo | 100.00% | 1.0× |
| Pocketful | 50.00% | 2.0× |
| Fyers | 50.00% | 2.0× |
| Share India | 37.99% | 2.6× |
Compare every broker on the INDOFARM MTF page.
About Indo Farm Equipment Ltd.: sector, index & market-cap context
Indo Farm Equipment Ltd. (INDOFARM) is a small-cap NSE-listed company, with a market capitalisation of ₹764 Cr. See more stocks on our screener.
How the INDOFARM Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of Indo Farm Equipment Ltd.'s public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
INDOFARM analysis, FAQs
Is Indo Farm Equipment Ltd. (INDOFARM) a good buy?
On the numbers, Indo Farm Equipment Ltd. (INDOFARM) tread carefully, a Downstox Snapshot Score of 34/100, weighing premium at 30.6× earnings, ROE of 4.5%, a 47% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is INDOFARM overvalued or undervalued?
INDOFARM trades at 30.6× earnings, premium versus the ~22× long-run Nifty average.
What is the INDOFARM share price target for 2031?
INDOFARM's probability-weighted 2031 median target is ₹130, with an 80% range of ₹28-₹610 (10,000-path Monte-Carlo).
What is the probability INDOFARM doubles in 5 years?
The modelled probability of INDOFARM reaching ₹318 (2×) within 5 years is 23%.
What is the bull case for INDOFARM?
Low price-to-book of 1.37×, the market is paying little over the company's net assets.
What are the risks in INDOFARM?
INDOFARM's P/E of 30.6x is lower than 45% of the 2,373 NSE companies in our screener, as of 9 Aug 2026. INDOFARM's return on equity of 4.5% ranks in the 28th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026. High historical volatility (54%/yr) means a wide, bumpy range of outcomes, size positions accordingly.